Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition
Drug Development Research · 2024
DOI: 10.1002/ddr.22133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Eman K A Abdelall und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
New chromene derivatives were synthesized based on 4‐(3,4‐dimethoxy)‐4 H ‐chromene scaffold. All target compounds exhibited cytotoxic activity against HepG2 cells (IC 50 = 2.40–141.22 μM). Chromens 5 and 9 showed superior cytotoxicity over staurosporine (IC 50 = 18.27 μM) and vinblastine (IC 50 = 5.20 μM). c‐Src kinase inhibition assay of compounds 5 and 9 displayed the dominant c‐Src inhibitory activity of 5 (IC 50 = 0.184 μM) over 9 (IC 50 = 0.288 μM). The safety of the most potent compound 5 against normal WI‐38 cells was confirmed via its IC 50 of 115.75 μM comparable with 5‐FU (IC 50 = 16.28 μM). Moreover, the promising chromene 5 displayed potent cytotoxicity against resistant HepG2 cells with IC 50 of 26.03 μM comparable with 5‐FU (IC 50 = 42.68 μM). The most active chromene 5 arrested the HepG2 cell cycle at the S phase and induced a 29‐fold increase in the total number of apoptotic cells indicating pre‐G1 apoptosis. The ability of compound 5 to induce apoptosis was supported via elevation of caspase‐3, caspase‐7, caspase‐9 and proapoptotic Bax protein levels in addition to downregulation of the antiapoptotic Bcl2 protein. Molecular docking studies of compound 5 showed good binding interaction pattern inside c‐Src kinase enzyme active site.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
ORCID-Profile: Heba A H Elshemy, Madlen B Labib
Zitieren
APA
Abdelall, E. K. A., Elshemy, H. A. H., Labib, M. B., & Mohamed, F. E. A. (2024). Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition. Drug Development Research. https://doi.org/10.1002/ddr.22133
Vancouver
Abdelall EKA, Elshemy HAH, Labib MB, Mohamed FEA. Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition. Drug Development Research. 2024. doi:10.1002/ddr.22133
BibTeX
@article{Abdelall2024,
author = {Abdelall, Eman K A and Elshemy, Heba A H and Labib, Madlen B and Mohamed, Fatma E A},
title = {Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition},
journal = {Drug Development Research},
year = {2024},
doi = {10.1002/ddr.22133}
}
EUVIMED